OncLive | Bringing the Global Oncology Community Together

Education ▼

PER is hosting the 2nd Annual International Congress on Oncology Pathology^™ | June 23rd in NYC Hematologic Malignancies Medical Crossfire in NYC on July 14th! Register today!

SPECIALTY TOPICS

CURRENTLY VIEWING
All Specialties

Gastrointestinal Cancer

Latest News

Perspectives on the Hematology-Oncology Fellowship Journey

Candace Haddox, MD, and Narjust Duma, MD, address the uncertainty, the victories, and the defeats common in oncology fellowship programs. Read More >>

Surviving the Marathon

2018 WORLD GI: Regorafenib Dose-Escalation Superior to Standard Dosing in mCRC

2018 WORLD GI: TAS-102 Benefit Consistent in Real-World Study for mCRC

2018 WORLD GI: O'Reilly Discusses Status of Immunotherapy Research in Pancreas Cancer

Ruxolitinib Reaches 55% Response Rate in Pivotal GVHD Trial

View More Stories >>

View Conference Coverage

2018 World Congress on GI Cancer

2018 European Hematology Association Congress

2018 State of the Science Summit on Genitourinary Cancers

2018 ASCO Annual Meeting

2018 ASPHO Conference

Dr. Galsky Discusses the Rationale for the IMvigor130 Study in Bladder Cancer

Dr. Ramalingam on Avelumab Plus Lorlatinib in NSCLC

Dr. Richardson Discusses the Results of the OPTIMISMM Trial in Myeloma

Dr. Novik on the Adoption of Biosimilars in Breast Cancer

Dr. Pecora on the Role of Stem Cell Transplant in Patients With Multiple Myeloma

Dr. Glaspy on Immunotherapy in Endometrial Cancer

Dr. O'Reilly on Immunotherapy in Pancreatic Cancer

OncLive houses thousands of videos that provide updates and information.
See more Videos

Managing Advanced Prostate Cancer in the Future

Hereditary Prostate Cancer Testing in Practice

Improvements in Detecting and Treating Metastatic CRPC

Renal Cell Carcinoma: An Evolving Treatment Landscape

OncLive houses thousands of videos that provide updates and information.
See more Videos

HCC: Emerging Therapies

Use of Immunotherapy for HCC

The Evolving Treatment Landscape of CLL

$Relapsed/Refractory CLL: Evaluating Other Novel Agents$

$Treatment of Relapsed/Refractory mHCC$

$Novel Approaches to Treating Relapsed/Refractory CLL$

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured

The Evolving Landscape of Immunotherapy for NSCLC

A video editorial series that features expert opinions on multiple areas of focus.

View more >>>

Featured

MRD-Positive ALL: Personal Approaches to Treatment

A unique opportunity to view lively discussions featuring peer-to-peer exchanges that provide authoritative insights, opinions, and perspectives on important issues facing today's cancer care professionals.

View more >>>

Featured Video

Immunotherapy in the Treatment of Follicular Lymphoma

Ian W. Flinn, MD, PhD; Grzegorz S. Nowakowski, MD; Loretta J. Nastoupil, MD; and Anas Younes, MD, reflect on the value of immunotherapy, immunotherapy combination strategies, and understanding the tumor microenvironment in treating follicular lymphoma.View now

FDA Approvals in Cervical Cancer, Ovarian Cancer, and CLL, and More